Teita Asano

4PUBLICATIONS
1CO-AUTHORS
Disease surveillancePredictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 03, 2024
Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan.

Katsumasa Nagano, Hiroaki Tsuchiya, Teita Asano

|May 23, 2024
Efficacy of golimumab in rheumatoid arthritis patients at high risk of a poor prognosis: Post hoc analysis of GO-FORTH study using cluster analysis.

Teita Asano, Yutaka Ishii, Hiroaki Tsuchiya

|Apr 10, 2024
Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study.

Masahiko Miyashiro, Teita Asano, Yutaka Ishii

|Jul 28, 2017
Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor.

Teita Asano, Ken-Ichiro Tanaka, Arisa Tada

Pageof 1

Frequent Collaborators

1 joint publications

Takayuki Matsumoto